|Title||Marketing of unproven stem cell-based interventions: A call to action.|
|Publication Type||Journal Article|
|Year of Publication||2017|
|Authors||Sipp D, Caulfield T, Kaye J, Barfoot J, C Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ|
|Journal||Sci Transl Med|
|Date Published||2017 Jul 05|
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.
|Alternate Journal||Sci Transl Med|